Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124929762 | 12492976 | 2 | F | 201601 | 20160609 | 20160623 | 20160721 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-37425BP | BOEHRINGER INGELHEIM | 83.70 | YR | F | Y | 0.00000 | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124929762 | 12492976 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | DAILY DOSE- 150 MG TWICE PRN | 559390 | 21698 | 150 | MG | TABLET | ||||||
| 124929762 | 12492976 | 2 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 559390 | 21698 | |||||||||||
| 124929762 | 12492976 | 3 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 559390 | 21698 | |||||||||||
| 124929762 | 12492976 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 2.5 MG | 0 | 2.5 | MG | TABLET | QD | ||||||
| 124929762 | 12492976 | 5 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0 | .05 | MG | TABLET | ||||||||
| 124929762 | 12492976 | 6 | C | Centrum Silver | MINERALSVITAMINS | 1 | Oral | 0 | TABLET | QD | |||||||||
| 124929762 | 12492976 | 7 | C | Citrical | CALCIUM CITRATE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124929762 | 12492976 | 1 | Pain |
| 124929762 | 12492976 | 2 | Gastrooesophageal reflux disease |
| 124929762 | 12492976 | 3 | Abdominal distension |
| 124929762 | 12492976 | 4 | Hypertension |
| 124929762 | 12492976 | 5 | Initial insomnia |
| 124929762 | 12492976 | 6 | Supplementation therapy |
| 124929762 | 12492976 | 7 | Osteoporosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124929762 | 12492976 | Incorrect drug administration duration | |
| 124929762 | 12492976 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124929762 | 12492976 | 1 | 20160129 | 0 | ||
| 124929762 | 12492976 | 4 | 2014 | 0 | ||
| 124929762 | 12492976 | 5 | 2011 | 0 |